Cleveland Clinic Taussig Cancer Institute
Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.
8-Year Follow-Up on MINDACT Trial for Adjuvant Chemo in HR+/HER2- BC: Do Genomically Low-Risk Tumors Benefit From Chemo? Is DMFS Improved?
Login to view comments.
Click here to Login
